Sahaar Pharma

What Sahaar Pharma does

Sahaar Pharma is a privately held pharmaceutical company founded in 2004, operating with approximately 11 employees according to available firmographic data. The company maintains a corporate web presence at sahaarpharma.com, though the website is currently inaccessible behind a loader/verification page that prevents extraction of substantive product, service, or corporate disclosures. No public ticker is listed, no parent company or subsidiaries are identified, and no regulatory actions, investments, or M&A activity are documented in the input set. Management team composition, office locations, technology stack, certifications, partnerships, and customer base are all unreported.

The available firmographic record is structurally minimal: no funding rounds, no revenue disclosure, no customer logos, no product catalog, and no pricing or GTM motion data are present. This limits any characterization of business model to inference from sector conventions — a small pharmaceutical entity of this vintage and headcount typically operates in one of three modes: branded generics distribution, third-party/contract manufacturing, or niche therapeutic product marketing, often within a single domestic market. Without primary disclosures, the specific segment, therapeutic area, regulatory licenses, and revenue mechanics cannot be determined from the provided material.

From an analyst standpoint, Sahaar Pharma presents as a low-data-profile micro-cap pharmaceutical operator. Investment-relevant attributes that are normally triaged — revenue trajectory, product pipeline, regulatory standing, customer concentration, capital structure, and leadership bench — are all absent from the input. Any diligence conclusion would require primary-source outreach, registry checks (e.g., local drug controller databases), and access to the company's verified website before this entity can be meaningfully benchmarked against comparable pharma SMEs.

Name

Sahaar Pharma

Website

https://sahaarpharma.com

Company type

Private

Headcount range

11–50 employees

Short description

Sahaar Pharma is a privately held, small-scale pharmaceutical company founded in 2004 with approximately 11 employees; no products, customers, financials, or business model details are disclosed in the available data.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

Keywords

• Pharmaceutical products
• Generic medicines
• Drug manufacturing
• Pharma distribution
• Medical supplies

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations

Core offering

Sahaar Pharma, founded in 2004, appears to be a small pharmaceutical company based on its name and ~11-employee headcount. The company operates a website at sahaarpharma.com, but the actual website content was not accessible during data collection — only a loading/verification page was displayed. Specific product formulations, therapeutic categories, manufacturing capabilities, and target indications could not be verified from the available source material.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Expansion highlights1 record

Broad incumbents

• Torrent Pharmaceuticals: Large India-based branded generics and specialty pharma company. Comparable in therapeutic category and Indian pharma footprint but operates at significantly greater scale with branded-marketing capabilities beyond the typical small generics company.
• Zydus Lifesciences (Cadila Healthcare): Diversified India-based pharmaceutical company spanning generics, APIs, biosimilars, and consumer healthcare. Comparable as an Indian generic-pharma peer but with a much broader portfolio including biologics and consumer health.

Direct peers

• Ajanta Pharma: India-based specialty generics company with branded and generic formulations across emerging markets. Comparable in product format and Indian generic-pharma orientation.
• Glenmark Pharmaceuticals: India-headquartered generics and specialty pharma company. Comparable in category (small-molecule generics), customer base (global generic markets), and business model, but significantly larger and more diversified.
• Mankind Pharma: India-based pharmaceutical company with a strong portfolio of generics and OTC products. Comparable as an Indian generic-pharma peer with similar product orientation, though at much larger scale.
• Granules India: India-based manufacturer of small-molecule finished dosages and APIs with a focus on high-volume generics. Comparable in category (small molecules), manufacturing model, and Indian pharma context.
• Alkem Laboratories: India-based generic pharmaceutical manufacturer across multiple therapeutic areas and dosage forms. Comparable as an Indian small-molecule generics peer with similar formulation-focused operations.
• Aurobindo Pharma: Large India-based generic small-molecule manufacturer with a broad product portfolio across multiple therapeutic areas. Highly comparable to a small Indian generic pharma in product category, target market, and regulatory orientation, though at vastly greater scale.
• Unichem Laboratories: India-based generic pharmaceutical company producing small-molecule formulations. Comparable in product category, geography of origin, and generics-focused business model.
• Ipca Laboratories: India-based generic manufacturer focused on small-molecule APIs and formulations. Comparable as an Indian small-molecule generics peer with similar export-driven commercial model.

Market position

Strengths2 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights2 records

Customer concentration

• LinkedInlinkedin.com/company/sahaar-pharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sahaar Pharma